British Journal of Clinical Pharmacology · 1985 · 28 citations · 13 references
PharmacyPharmacokineticsPharmacologyDialysisHemodialysisRenal PharmacokineticsChronic HemodialysisDialysis PharmacotherapyPharmacokinetics In Renal ImpairmentRenal Dose ModificationRenal PharmacologyDrug Clearance During HemodialysisDrug Clearance In DialysisHemodialysis PharmacokineticsNifedipine TherapyPeak Plasma Concentration ChangesPharmacokinetics In DialysisPharmacokinetics In Kidney DiseasePlasma Protein Binding Differences
To establish dosage recommendations in patients with end-stage renal disease undergoing chronic haemodialysis, nifedipine kinetics were studied between and during haemodialysis sessions. In eight patients, during the interdialytic period, peak plasma concentrations of nifedipine (29-332 ng/ml) were reached 0.5-1.0 h after administration of a single 10 mg oral dose. Elimination half-life and oral plasma clearance were respectively 2.6 +/- 0.5 h and 1 176 +/- 412 ml/min. Nifedipine plasma protein binding was decreased in uraemic patients (88.8 +/- 0.3% vs 94.4 +/- 0.1%) but not affected by haemodialysis. Removal by haemodialysis was low: the dialyser extraction ratio and the dialysis clearance were respectively 2.3 +/- 0.8% and 2.8 +/- 0.9 ml/min.
13
Pharmacokinetics and metabolism of nifedipine.
Klaus D. Raemsch, Jürg M. Sommer · Hypertension · 1983 · 226 citations
Nifedipine: Kinetics and dynamics in healthy subjects
C. H. Kleinbloesem, P. van Brummelen, J A Van De Linde et al. · Clinical Pharmacology & Therapeutics · 1984 · 223 citations